Investor Relations

Date: March 12-14 2023

Date:January 11, 2023 5:00 pm PST

Join us for an evening dedicated to networking and investment opportunities with top Italian pharma and biotech companies and discover why Italy is one of the world's greatest centers

Location: Italian Innovation Centre - INNOVIT, San Francisco at 710 Sansome Street, CA.

Date: November 7, 2022

Signs of intra-tumor pro-inflammatory state in patients; Temferon™ induced immune system reset in preclinical studies; Macrophage and T cell profiles in patients’ tumor microenvironment echo preclinical findings

Title:Genenta Corporate Presentation
Time: January 20, 2022

• Current dose escalation study data shows a median overall survival of 17 months
• Adding cohort to Phase 1/2a trial in GBM to assess additional conditioning regimen
• Cash and cash equivalents of €34.7 million as of June 30, 2022, providing a cash runway until the end of 2024
• €1.8 million unrealized foreign exchange gain